EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The application of artificial intelligence to accelerate G protein‐coupled receptor drug discovery

Anh T N Nguyen, Diep T N Nguyen, Huan Yee Koh, Jason Toskov, William MacLean, Andrew Xu, Daokun Zhang, Geoffrey I Webb, Lauren T May iD, Michelle L Halls iD

British Journal of Pharmacology · 2024-07 · 181 (14) · 2371-2384

DOI: 10.1111/bph.16140 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift British Journal of Pharmacology, online erschienen am 26.05.2023. Verfasst von Anh T N Nguyen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Drug Discovery, Artificial Intelligence. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, National Heart Foundation of Australia, The Cross Family and The Frank Alexander Charitable Trusts.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The application of artificial intelligence (AI) approaches to drug discovery for G protein‐coupled receptors (GPCRs) is a rapidly expanding area. Artificial intelligence can be used at multiple stages during the drug discovery process, from aiding our understanding of the fundamental actions of GPCRs to the discovery of new ligand‐GPCR interactions or the prediction of clinical responses. Here, we provide an overview of the concepts behind artificial intelligence, including the subfields of machine learning and deep learning. We summarise the published applications of artificial intelligence to different stages of the GPCR drug discovery process. Finally, we reflect on the benefits and limitations of artificial intelligence and share our vision for the exciting potential for further development of applications to aid GPCR drug discovery. In addition to making the drug discovery process “faster, smarter and cheaper,” we anticipate that the application of artificial intelligence will create exciting new opportunities for GPCR drug discovery. LINKED ARTICLES This article is part of a themed issue Therapeutic Targeting of G Protein‐Coupled Receptors: hot topics from the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists 2021 Virtual Annual Scientific Meeting. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v181.14/issuetoc

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, G-Protein-CoupledDrug DiscoveryArtificial IntelligenceHumansAnimalsMachine LearningLigands

Stichwörter der Autor:innen

G protein‐coupled receptorartificial intelligencedeep learningdrug discoverymachine learning

Substanzen

Receptors, G-Protein-CoupledLigands

Autor:innen und Institutionen

  • Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
  • Department of Information Technology, Faculty of Engineering and Technology, Vietnam National University, Cau Giay, Hanoi, Vietnam.
  • Monash Data Futures Institute and Department of Data Science and Artificial Intelligence, Monash University, Clayton, Victoria, Australia.
  • Monash DeepNeuron, Monash University, Clayton, Victoria, Australia.

ORCID-Profile: Lauren T May, Michelle L Halls

Förderung

  • National Health and Medical Research Council
  • National Heart Foundation of Australia
  • The Cross Family and The Frank Alexander Charitable Trusts

Zitieren

APA

Nguyen, A. T. N., Nguyen, D. T. N., Koh, H. Y., Toskov, J., MacLean, W., Xu, A., Zhang, D., Webb, G. I., May, L. T., & Halls, M. L. (2024). The application of artificial intelligence to accelerate G protein‐coupled receptor drug discovery. British Journal of Pharmacology, 181(14), 2371-2384. https://doi.org/10.1111/bph.16140

Vancouver

Nguyen ATN, Nguyen DTN, Koh HY, Toskov J, MacLean W, Xu A, et al. The application of artificial intelligence to accelerate G protein‐coupled receptor drug discovery. British Journal of Pharmacology. 2024;181(14):2371-2384. doi:10.1111/bph.16140

BibTeX
@article{Nguyen2024,
  author = {Nguyen, Anh T N and Nguyen, Diep T N and Koh, Huan Yee and Toskov, Jason and MacLean, William and Xu, Andrew and Zhang, Daokun and Webb, Geoffrey I and May, Lauren T and Halls, Michelle L},
  title = {The application of artificial intelligence to accelerate G protein‐coupled receptor drug discovery},
  journal = {British Journal of Pharmacology},
  year = {2024},
  volume = {181},
  number = {14},
  pages = {2371--2384},
  doi = {10.1111/bph.16140}
}
Kostenlos starten →